Telisotuzumab vedotin (ABBV-399). Non-Small Cell Lung Cancer. Phase 2. Learn about Telisotuzumab vedotin (ABBV-399) · TNB-383B *. Multiple Myeloma. Phase 1.
確定! 回上一頁